Urovant Sciences GmbH

Clinical trials sponsored by Urovant Sciences GmbH, explained in plain language.

Now part of Sumitomo Pharma Co., Ltd. 4506 TOKYO

A specialty pharmaceutical company focused on urology treatments, subsidiary of Sumitomo Pharma.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Trials to join now! 1

Daily pill aims to improve bladder function in children with spinal conditions

Disease control Recruiting now

This study tests a daily pill called vibegron to see if it safely improves bladder control in children aged 2 to 18 with neurogenic detrusor overactivity (NDO), a condition where the bladder contracts too often due to nerve damage. Participants must already use a catheter to empt…

Phase 2/3 • Sponsor: Urovant Sciences GmbH • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

Urovant Sciences GmbH

Daily pill aims to improve bladder function in children with spinal conditions